Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
NCT06169826
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
withdrawn by the PI
Conditions
Alzheimer Disease
Interventions
DRUG:
l-Histidine
OTHER:
Control
Sponsor
Wake Forest University Health Sciences